W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

The Meeting of the Transparency Council No. 35/2022 of 05.09.2022

The agenda includes:

Preparing a position on the legitimacy of granting reimbursement approval for the medicinal product Tript-OH (oxitriptan) for the indication: tetrahydrobiopterin deficiency.

Preparing opinions on draft health policy programmes of local government units:

  • ,,Infertility treatment with the method of in vitro fertilization for the residents of the city of Jelenia Góra for years 2022-2026”,
  • ,,Health policy programme for the diagnosis and treatment of infertility for residents of the Poviat of Olkusz”,
  • ,,Health policy programme for the prevention of meningococcal infections for children in the Municipality of Kielce”.

Preparation of an opinion on the reimbursement of medicines containing the active substance arsenic trioxide for the indication: C92.4 acute promyelocytic leukaemia for: patients under 18 years of age diagnosed with acute promyelocytic leukaemia characterised by translocation t (15;17) and/or presence of PML/RAR-alpha gene.